The Department of Ophthalmology of the University of Cologne was honored to host Associate Professor Takefumi Yamaguchi from Tokyo Dental College. During his recent visit, he attended corneal surgeries with a rich exchange on surgery techniques with Prof. Cursiefen and his team. Afterwards Prof. Yamaguchi gave a guest lecture titled "Visual optics in corneal transplantation to achieve better visual acuity"

Univ.-Prof. Dr. Claus Cursiefen, Director of the Center for Ophthalmology at the University Hospital of Cologne and the Faculty of Medicine, has been elected to Chair LVI of the international university ophthalmological association at the annual meeting of the Academia Ophthalmologica Internationalis (AOI) in Prague.

The Center for Ophthalmology at the University Hospital of Cologne has once again received the most mentions in the field of ophthalmology in the Focus list of physicians throughout Germany. A total of fourteen doctors were named in the current list of doctors in "Focus Gesundheit".

The Initiator Initiated Trial (IIT) entitled "Comparison of Positioning, Schlemm Canal Dilation and Intraocular Pressure after Hydrus Microstent vs. I Stent Injection in Combination with Cataract Surgery" conducted by the Center for Ophthalmology at the University Hospital of Cologne under the leadership of Univ.-Prof. Dr. Verena Prokosch has been approved by the Alcon Global Grant Committee and will be funded with approximately 84,500 Euros.

The National Academy of Sciences "Leopoldina" and the German Ophthalmological Society (DOG) support a symposium on "The aging eye: unmet medical needs, societal implications and future therapeutic perspectives", which will take place on May 25 and 26, 2023 at the Center for Ophthalmology, University Hospital Cologne.

Prof. Dr. Mike (Przemlysaw) Sapieha, an expert in translational eye research at the University of Montreal in Canada, visited the FOR2240 research group and the Chair of Experimental Immunology of the Eye at the Center for Ophthalmology of the University Hospital Cologne and the Faculty of Medicine at the end of March. For several years, there has been a close research collaboration on the role of the immune system in age-related macular degeneration (AMD), the most common cause of vision loss in older age.

The European Union has supported a research proposal on new therapies to restore visual acuity in rare and severe ocular surface diseases under the Horizon Health program. The RESTORE VISION consortium, consisting of the Universities of Cologne, Galway, Milan, Linjöping and Paris, and four industrial partners, has received a total of eight million euros in funding over four years.